» Articles » PMID: 37815180

Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2023 Oct 10
PMID 37815180
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVDs) are serious life-threatening illnesses and significant problematic issues for public health having a heavy economic burden on all society worldwide. The high incidence of these diseases as well as high mortality rates make them the leading causes of death and disability. Therefore, finding novel and more effective therapeutic methods is urgently required. Gallic acid, an herbal medicine with numerous biological properties, has been utilized in the treatment of various diseases for thousands of years. It has been demonstrated that gallic acid possesses pharmacological potential in regulating several molecular and cellular processes such as apoptosis and autophagy. Moreover, gallic acid has been investigated in the treatment of CVDs both in vivo and in vitro. Herein, we aimed to review the available evidence on the therapeutic application of gallic acid for CVDs including myocardial ischemia-reperfusion injury and infarction, drug-induced cardiotoxicity, hypertension, cardiac fibrosis, and heart failure, with a focus on underlying mechanisms.

Citing Articles

Food Components in Health Promotion and Disease Prevention.

Chiavaroli A, Brunetti L Foods. 2023; 12(24).

PMID: 38137205 PMC: 10743150. DOI: 10.3390/foods12244401.

References
1.
Benjamin E, Muntner P, Alonso A, Bittencourt M, Callaway C, Carson A . Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528. DOI: 10.1161/CIR.0000000000000659. View

2.
Lorber D . Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2014; 7:169-83. PMC: 4043722. DOI: 10.2147/DMSO.S61438. View

3.
Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 63(25 Pt B):2889-934. DOI: 10.1016/j.jacc.2013.11.002. View

4.
Zhang H, Wang L . Theoretical elucidation on structure-antioxidant activity relationships for indolinonic hydroxylamines. Bioorg Med Chem Lett. 2002; 12(2):225-7. DOI: 10.1016/s0960-894x(01)00724-7. View

5.
Stanely Mainzen Prince P, Priscilla H, Devika P . Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharmacol. 2009; 615(1-3):139-43. DOI: 10.1016/j.ejphar.2009.05.003. View